Many patients and healthcare providers face uncertainty about the appropriate next steps once weight loss targets have been met
Semaglutide and tirzepatide can cause nausea, diarrhea, vomiting, constipation, abdominal (stomach) discomfort and pain, injection site reactions, fatigue, hypersensitivity (allergic) reactions (typically fever and rash), burping, hair loss and gastroesophageal reflux disease
(2023, August 4)
Build My Treatment Plan Get matched with specific treatments Complete in a few minutes Confidential results only shared with your provider Pre & Post Care Instructions Getting Ready for Medical Weight Loss Start establishing healthy habits like eating a balanced diet and exercising regularly
While the neutralizing antibody MEDI-573 has been reported to avoid disruption of the growth hormone (GH)/IGF-1 feedback system, another neutralizing antibody (BI 83645-xentuzumab) induced GH increases in mice
A licensed provider can adjust your dose when you need it